Vanda Pharmaceuticals Inc — 貸借対照表 (NASDAQ:VNDA) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M 負債合計 80.19 M88.86 M107.05 M103.53 M117.66 M161.76 M 純資産合計 453.27 M504.93 M527.2 M544.91 M538.55 M327.19 M 負債および純資産合計 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M 有利子負債合計 —————— 純負債 ——————

ニュース

Vanda Pharmaceuticalsがシチズンズ・ライフサイエンス会議で戦略的成長の見通しを示す

Vanda Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth Insights

Micron and Palantir among market cap stock movers on Tuesday

Truist、医薬品パイプラインを評価しVanda Pharmaceuticals株を買い推奨で開始

Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline

FDAがVandaのHetlioz時差ぼけ適応申請に関する公聴会を承認

FDA grants Vanda hearing on Hetlioz jet lag application

FDAがVandaの希少皮膚疾患治療薬imsidolimabの申請を受理

Vanda Pharmaceuticals Breaks Through With FDA Approval, Decision Date For Skin Drug - Vanda Pharmaceuticals (NASDAQ:VNDA)

American Express, Oracle among market cap stock movers on Monday

H.C. WainwrightがFDA承認を受けてVanda Pharmaceuticalsの目標株価を24ドルに引き上げ

Vanda Pharmaceuticals stock price target raised to $24 by H.C. Wainwright on FDA approval